Literature DB >> 17339835

Physiological activities of carbon monoxide-releasing molecules: Ca ira.

P K Chatterjee1.   

Abstract

In this issue of British Journal of Pharmacology, Megías and colleagues demonstrate how preincubation of human colonic Caco-2 cells with CORM-2, a carbon monoxide releasing molecule (CO-RM), reduces the expression of inducible nitric oxide synthase, interleukin (IL)-6 and IL-8 caused by proinflammatory cytokines. A role for IL-6 in the regulation of metalloproteinase (MMP)-7 expression by CORM-2 is described. However, it is the demonstration that CORM-2 inhibits MMP-7 or matrilysin expression, which is most intriguing as this small MMP has been implicated in carcinogenesis. Thus, CO-RMs appear to now possess chemoprotective properties and, in this particular case, may influence inflammation-induced colon carcinogenesis via modulation of nuclear factors participating in the transcription of genes implicated in the development of intestinal inflammation and cancer. This report opens yet another door for research involving these exciting molecules and it is now clear that further discoveries of the beneficial properties of CO-RMs will go on.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17339835      PMCID: PMC2013920          DOI: 10.1038/sj.bjp.0707185

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Heme oxygenase-1 attenuates interleukin-1beta-induced nitric oxide synthase expression in vascular smooth muscle cells.

Authors:  Nian-Chung Yang; Liang-Huei Lu; Yung-Hsi Kao; Lee-Young Chau
Journal:  J Biomed Sci       Date:  2004 Nov-Dec       Impact factor: 8.410

2.  Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages.

Authors:  Philip Sawle; Roberta Foresti; Brian E Mann; Tony R Johnson; Colin J Green; Roberto Motterlini
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

3.  The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells.

Authors:  J Megías; J Busserolles; M J Alcaraz
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

4.  Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities.

Authors:  Roberto Motterlini; James E Clark; Roberta Foresti; Padmini Sarathchandra; Brian E Mann; Colin J Green
Journal:  Circ Res       Date:  2002-02-08       Impact factor: 17.367

Review 5.  The role of matrix metalloproteinase 7 in innate immunity.

Authors:  Bernard Burke
Journal:  Immunobiology       Date:  2004       Impact factor: 3.144

Review 6.  Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?

Authors:  Ben Wielockx; Claude Libert; Carole Wilson
Journal:  Cytokine Growth Factor Rev       Date:  2004 Apr-Jun       Impact factor: 7.638

7.  Water-soluble carbon monoxide-releasing molecules: helping to elucidate the vascular activity of the 'silent killer'.

Authors:  Prabal Kumar Chatterjee
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

8.  Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability.

Authors:  Q A Albakri; D J Stuehr
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

9.  Opposite effect of oxidative stress on inducible nitric oxide synthase and haem oxygenase-1 expression in intestinal inflammation: anti-inflammatory effect of carbon monoxide.

Authors:  Gerard Dijkstra; Hans Blokzijl; Lisette Bok; Manon Homan; Harry van Goor; Klaas Nico Faber; Peter L M Jansen; Han Moshage
Journal:  J Pathol       Date:  2004-11       Impact factor: 7.996

Review 10.  Bioactivity and pharmacological actions of carbon monoxide-releasing molecules.

Authors:  Roberto Motterlini; Brian E Mann; Tony R Johnson; James E Clark; Roberta Foresti; Colin J Green
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

View more
  3 in total

Review 1.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

Review 2.  Aspects of Carbon Monoxide in Form of CO-Releasing Molecules Used in Cancer Treatment: More Light on the Way.

Authors:  Malamati Kourti; Wen G Jiang; Jun Cai
Journal:  Oxid Med Cell Longev       Date:  2017-02-13       Impact factor: 6.543

3.  Carbon monoxide inhibits L-type Ca2+ channels via redox modulation of key cysteine residues by mitochondrial reactive oxygen species.

Authors:  Jason L Scragg; Mark L Dallas; Jenny A Wilkinson; Gyula Varadi; Chris Peers
Journal:  J Biol Chem       Date:  2008-07-01       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.